NExT DTP-23-019 GMP PRODUCTION OF 40MG CAPSULES OF Z-ENDOXIFEN

NIH RePORTER · NIH · N02 · $140,000 · view on reporter.nih.gov ↗

Abstract

The Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI) develops cancer therapeutic agents under the Developmental Therapeutics Program (DTP). Part of the DTP services includes formulation and production of clinical dosage forms of the agents selected by DCTD for further development.

Key facts

NIH application ID: 10948454
Project number: 75N98019D00058-0-759102300002-1
Recipient: IRISYS, INC.
Principal Investigator: ROBERT GIANNINI
Activity code: N02
Funding institute: NIH
Fiscal year: 2023
Award amount: $140,000
Award type: —
Project period: 2023-04-24 → 2023-07-23